Office of Research

Pathway to Stop Diabetes


Pathwayseeks exceptional nominees from a broad range of disciplines, including medicine, biology, chemistry, engineering, physics, and mathematics. The Association encourages nomination of individuals from diverse backgrounds, including minorities that are underrepresented in research. For the purposes of this program, underrepresented minorities are defined as individuals of African American, Hispanic or Latino, American Indian or Alaskan Native, and Native Hawaiian or Pacific Islander descent.


To accelerate the research needed to discover solutions and ultimately cure this deadly epidemic, the American Diabetes Association is launching a bold new initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground‐breaking discoveries in diabetes prevention, treatment and cures.


Pathway will support creative scientists early in their diabetes research careers, or investigators who are established in other disciplines but would like to expand their focus to diabetes research. Through awards of $1.625 million over the course of five to seven years, the program will allow researchers to have the freedom, autonomy, time and focus needed to explore new ideas.


Pathway will consider applications directed toward topics relevant to the prevention, treatment and cure of all diabetes types (type 1, type 2 and gestational), diabetes‐related disease states (obesity, pre‐diabetes, and other insulin resistant states) and diabetes complications. The program intends to attract individuals with a broad range of expertise in various science and technology disciplines, including medicine, biology, chemistry, computing and engineering, to the field of diabetes research.


Each institution is allowed a maximum of one nomination. The nomination can be in either of the two available Pathway award types

Eligibility Requirements

Nominees must have the appropriate full‐time position to be eligible for the award at the sponsoring institution (postdoctoral fellow for Initiator, independent faculty appointment for Accelerator). Nominees are required to devote at least 75% of their total time and effort to research during the funding period. Please see the above referenced/attached award program PDFs for specific eligibility requirements.

Application Instructions

Please submit a two-page letter of intent with a list of all anticipated investigators, description of proposed aims and approach, Biosketch of the PI, and a letter of support from the Dean or Chair to by Thursday, May 16, 2013. This letter of support signifies that the Dean or Chair have ensured that the nominee and application are likely to be of sufficient quality to be competitive nationally. The full nomination is due to the sponsor on 8/16/13, so you will need to have your materials in to the Office of Sponsored Programs by 8/9/13 for processing if given the go ahead by the review committee.

Opportunity Details

Program web page

Program Announcement No.


05/16/2013 UW Internal Deadline Closed
08/09/2013 OSP Deadline
08/16/2013 Sponsor Deadline

American Diabetes Association (ADA)

Funding amount


Maximum Number of Applications

1 ((for either the Diabetes Research Career Initiator or Research Accelerator award))

Eligible groups
  • All campus

Inquiries and Contact Information

Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.

For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at